A phase I study of a wild-type reovirus (Reolysin) given intravenously to patients with advanced malignancies.

L Vidal, H Pandha, K Harrington, P Fong, H Shaw, M Barrett, D Leader, C White, K Twigger, M Coffey, …

CLINICAL CANCER RESEARCH, Vol.11(24), pp.9106S-9107S

AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics (Philadelphia, PA, 14/11/2005–18/11/2005)

15/12/2005

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000234382701152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

Details

Title: A phase I study of a wild-type reovirus (Reolysin) given intravenously to patients with advanced malignancies.
Creators: L Vidal
H Pandha
K Harrington
P Fong
H Shaw
M Barrett
D Leader
C White
K Twigger
M Coffey
B Thompson
S Kaye
J De-Bono
Contributors: AMER ASSOC CANCER RESEARCH (Publisher)
Publication Details: CLINICAL CANCER RESEARCH, Vol.11(24), pp.9106S-9107S
Conference: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics (Philadelphia, PA, 14/11/2005–18/11/2005)
Publication Date: 15/12/2005
Identifiers: 99514049102346
Academic Unit: University of Surrey
Resource Type: Conference presentation

A phase I study of a wild-type reovirus (Reolysin) given intravenously to patients with advanced malignancies.

Abstract

Files and links (1)

Metrics

Details

Usage Policy